Conditions: Hypercholesterolemia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 152
Healthy volunteers: no

Brief summary:
This study will examine the effect of ezetimibe on glucose metabolism in participants with Type 2 diabetes and hypercholesterolemia.The primary hypothesis is that change in glycated hemoglobin (HbA1c) from baseline in the ezetimibe treatment group will be non-inferior to the placebo control group.

Detailed description:

Arms:
arm 1: 10 mg oral dose once daily for 24 weeks arm 2: Placebo to match ezetimibe orally once daily for 24 weeks

Interventions: intervention 1: Ezetimibe intervention 2: Placebo
Intervention descriptions: intervention 1: 10 mg oral dose once daily for 24 weeks intervention 2: Placebo to match ezetimibe orally once daily for 24 weeks.

Protocol document: